BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Oncoscience AG 

Hafenstraße 32

Wedel    22880  Germany
Phone: 49-4103-180-880 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
YM BioSciences (YM.TO)' Subsidary Resolves Proposed Arbitration with Oncoscience AG 6/29/2009 10:32:14 AM    More...
YM BioSciences (YM.TO) Subsidary Notifies Oncoscience AG of Intention to Submit Issues for Arbitration 11/17/2008 10:42:31 AM    More...
YM BioSciences (YM.TO)', European Partner, Oncoscience AG, Announces Initiation Of Advanced Nimotuzumab Trials In Adult Glioma And Pancreatic Cancer 8/21/2007 7:37:40 AM    More...
Oncoscience AG Announces Completion of Patient Enrollment in Phase 3 Trial 8/15/2007 8:07:46 AM    More...
YM BioSciences (YM.TO)' Partner, Oncoscience AG, Commences Patient Treatment In Phase III Trial In Germany With Nimotuzumab 4/27/2006 10:21:37 AM    More...
YM BioSciences (YM.TO)' Partner, Oncoscience AG, Cleared For Phase III Trial In Germany With Nimotuzumab 3/28/2006 10:27:00 AM    More...
YM BioSciences' (YM.TO) TheraCIM Receives Investigator Sponsored IND From FDA 10/19/2005 5:13:02 PM    More...
YM BioSciences (YM.TO) Partner, Oncoscience AG, Reports Update Of Pediatric Brain Cancer Data 10/19/2005 5:12:58 PM    More...
YM BioSciences (YM.TO) And Oncoscience AG Report Response Rate Of 35.3% In Pediatric Glioma 10/19/2005 5:12:52 PM    More...
YM BioSciences (YM.TO) And Oncoscience AG Achieve Clinical Milestone 10/19/2005 5:12:32 PM    More...
12